Gland Pharma Ltd.(IN:GLAND)
₹3,291.05+61.25 (+1.90%)
IN:GLAND
Gland Pharma Ltd. Revenue
₹3,291.05
At close:+61.25 (+1.90%)
Want to see IN:GLAND full AI Analyst Report?
Gland Pharma Ltd. (GLAND) Revenue
1 Followers
Gland Pharma Ltd. Revenue
Gland Pharma Ltd. had a revenue of 19.03B in the quarter ending Sep 30, 2026, with 5.69%. This bring the company's revenue in the last twelve months to 71.41B, Increased 6.18%. In the fiscal year ending Mar 31, 2026, Gland Pharma Ltd. had annual revenue of 64.31B with 14.50% growth.
- Revenue (ttm)
- 71.41B
- Revenue Growth
- 21.90%
- P/S Ratio
- 8.44
- Revenue/Employee
- INR 14,844,529
- Employees
- 4,332
- Market Cap
- INR 543.06B
Revenue Chart
Gland Pharma Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 64.31B | 8.14B | 14.50% |
| Mar 31, 2025 | 56.17B | -482.18M | -0.85% |
| Mar 31, 2024 | 56.65B | 20.40B | 56.29% |
| Mar 31, 2023 | 36.25B | -7.76B | -17.64% |
| Mar 31, 2022 | 44.01B | 9.38B | 27.08% |
| Mar 31, 2021 | 34.63B | 8.30B | 31.51% |
| Mar 31, 2020 | 26.33B | 5.89B | 28.81% |
| Mar 31, 2019 | 20.44B | 4.24B | 26.19% |
| Mar 31, 2018 | 16.20B | 1.41B | 9.52% |
| Mar 31, 2017 | 14.79B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:GLAND | 71.41B |
| IN:ABBOTINDIA | 69.29B |
| IN:CIPLA | 279.49B |
| IN:GLAXO | 41.59B |
| IN:MARKSANS | 33.92B |
| IN:PFIZER | 26.54B |

